Topics
-
Next-Generation Healthcare Marketing: The Rise of Programmatic
Discover the rise and future of programmatic marketing for healthcare, transforming patient engagement.
Read More » -
Precision Targeting: The Promise of Programmatic Marketing for Pharma Audiences
In the rapidly evolving landscape of pharmaceutical marketing, programmatic marketing continues to offer the promise of both precision and efficiency.…
Read More » -
AstraZeneca Launches New Health-Tech Business To Accelerate Trials
As the need for speed continues to drive innovation across the pharmaceutical ecosystem, AstraZeneca has launched a new stand-alone business…
Read More » -
Enhancing Healthcare Campaigns: Reaching Patients Through Programmatic Marketing
Explore how reaching patients through programmatic marketing enhances healthcare campaigns, with future trends.
Read More » -
“Visual Health AI”: Be My Eyes App Links to Microsoft Disability Answer Desk With Stunning Results
If you are ever on Jeopardy and get asked about Alexander Graham Bell – it turns out that his inspiration…
Read More » -
Maximize Your Impact: Advanced Programmatic Advertising Strategies for HCPs
Boost your healthcare marketing with advanced programmatic advertising strategies for HCPs.
Read More » -
Revolutionizing Healthcare: How Mark Cuban’s Innovative Drug Pricing Model is Shaking Up Big Pharma and Inspiring Giants Like Cigna
Mark Cuban’s Cost Plus Drug Company represents a significant shift in the pharmaceutical landscape, aiming to make medicines more accessible…
Read More » -
Revolutionizing Patient Education: 5 Groundbreaking Impacts of GPTs in Healthcare
The integration of Generative Pre-trained Transformers (GPTs) into the healthcare sector is poised to revolutionize patient education, heralding a new…
Read More » -
The Transformative Power of High-Quality Data: How Small Investments in Data Quality Yield Massive Downstream ROI for Pharma Ad Spend
In today’s rapidly evolving pharmaceutical marketing landscape, the value of quality data cannot be overstated. Investing in high-quality data is…
Read More » -
Diabetes, weight loss drugs drive growth for Novo and Lilly despite shortages
Novo Nordisk (NVO) and Eli Lilly (LLY) stocks were both boosted by sales of their Type 2 diabetes and weight loss drugs…
Read More »